Estrogen dose: the cardiovascular impact

By Panay N.  

Climacteric, Vol. 12, Iss. 1, 2009-08 ,pp. : 91-95

Informa Healthcare

Access to resources Recommend Favorite

Estrogen receptor actions on vascular biology and inflammation: implications in vascular pathophysiology

By Arnal J. F.   Laurell H.   Fontaine C.   Billon A.   Calippe B.   Lenfant F.   Gourdy P.  

Climacteric, Vol. 12, Iss. 1, 2009-08 ,pp. : 12-17

Informa Healthcare

Access to resources Recommend Favorite

Endothelin levels decrease after oral and nonoral estrogen in postmenopausal women with increased cardiovascular risk factors

By Wilcox J.G.   Hatch I.E.   Gentzschein E.   Stanczyk F.Z.   Lobo R.A.  

Fertility and Sterility, Vol. 67, Iss. 2, 1997-02 ,pp. : 273-277

Elsevier

Access to resources Recommend Favorite

Clinical issues regarding cardiovascular disease and selective estrogen receptor modulators in postmenopausal women

By de Villiers T. J.  

Climacteric, Vol. 12, Iss. 1, 2009-08 ,pp. : 108-111

Informa Healthcare

Access to resources Recommend Favorite

Adipose tissue, insulin resistance and low-grade inflammation: implications for atherogenesis and the cardiovascular harm of estrogen plus progestogen therapy

By Tanko L. B.   Christiansen C.  

Climacteric, Vol. 9, Iss. 3, 2006-06 ,pp. : 169-180

Informa Healthcare

Access to resources Recommend Favorite